Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Self-reported measures of antiretroviral adherence vary greatly in recall time periods and response tasks. To determine which time frame is most accurate, we compared 3-, 7-day, and 1-month self-reports with data from medication event monitoring system (MEMS). To determine which response task is most accurate we compared three different 1-month self-report tasks (frequency, percent, and rating) to MEMS. We analyzed 643 study visits made by 156 participants. Over-reporting (self-report minus MEMS) was significantly less for the 1-month recall period (9%) than for the 3 (17%) or 7-day (14%) periods. Over-reporting was significantly less for the 1-month rating task (3%) than for the 1-month frequency and percent tasks (both 12%). We conclude that 1-month recall periods may be more accurate than 3- or 7-day periods, and that items that ask respondents to rate their adherence may be more accurate than those that ask about frequencies or percents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a 5-item scale that has been shown sensitive to variations in health states related to HIV, mental health,53,54 and tobacco use.55,56”
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 2×
“We use the Medical Outcome Study 12-item short-form health survey to assess physical and mental health (Ware et al. 1996), and the PC-SAD to assess depression (Rogers et al. 2002).”
MethodPalella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405 · cited 1×
“Highly active antiretroviral therapy (HAART) has led to a dramatic decline in human immunodeficiency virus (HIV) mortality and morbidity (Hogg et al. 1998; Palella et al. 1998).”
BackgroundAdherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289 · cited 1×
“Both clinical trials and cohort studies have shown that adherence to antiretroviral (ARV) medication is one of the most important factors for the success of HAART (Arnsten et al. 2001; Bangsberg et al. 2001; Chesney et al.1999; Paterson et al. 2000).”
BackgroundPreston, C. C., & Colman, A. M. (2000) · Acta Psychologica · doi:10.1016/s0001-6918(99)00050-5 · Cited by 2,106 · cited 2×
“For analysis we assigned the six categories scores of 0, 20, 40, 60, 80, and 100, with 100 being the best adherence ( Preston and Colman 2000 ).”
MethodChesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428 · cited 1×
“The widely used Aids Clinical Trials Group (ACTG) adherence instruments employs a 4-day recall period (Chesney et al. 2000).”
MethodPeters, E., Västfjäll, D., Slovic, P., Mertz, C. K., Mazzocco, K., & Dickert, S. (2006) · Psychological Science · doi:10.1111/j.1467-9280.2006.01720.x · Cited by 1,180
The Role of Numeracy in Understanding the Benefit of Screening Mammography
Schwartz, L. M., Woloshin, S., Black, W. C., & Welch, H. G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00003 · Cited by 1,130 · cited 1×
“Recognition of health numeracy as an issue for patient self-management and participatory decision-making is growing (Apter et al. 2006; Gazmararian et al. 1999; Montori and Rothman 2005; Peters et al. 2006; Schwartz et al. 1997; Woloshin et al. 2005).”
BackgroundBangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033 · cited 1×
“Poor adherence is associated with treatment failure, resistance, and the transmission of resistant viruses (Bangsberg et al. 2000; Vanhove et al.1996).”
Background
Research works printed but not linked: 2
- Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl A), S271–S278.
- Montori, V. M., Leung, T. W., Thompson, C. A., Chung, J. A., Capes, S. E., & Smith, S. A. (2004). Choice of risk representation to enable diabetes decision-making. Diabetes, 53(Suppl 2), A225.
Cited by
Items 201–300 of 360
Giordano, T. P., Rodriguez, S., Zhang, H., Kallen, M. A., Jibaja‐Weiss, M. L., Buscher, A. L., Arya, M., Suarez-Almazor, M. E., & Ross, M. W. (2012) · AIDS and Behavior · doi:10.1007/s10461-012-0295-x · Cited by 16
“Adherence was assessed by self-report using a validated item based on a visual analogue scale, which asks the participant to report their adherence over the last 4 weeks [21, 22], a recall period supported by recent literature [23].”
BackgroundMethodCrane, H. M., Nance, R. M., Merrill, J. O., Hutton, H. E., Chander, G., McCaul, M. E., Mathews, W. C., Fredericksen, R. J., Simoni, J. M., Mayer, K. H., et al. (2016) · AIDS Care · doi:10.1080/09540121.2016.1204418 · Cited by 16
“ART adherence is measured by a 30-day visual analog scale item (VAS) (Amico et al., 2006), a 30-day self-rating item (Feldman et al., 2012; Lu et al., 2008), and by items from the Adult AIDS Clinical Trial Group (AACTG) adherence measure, including an item on time since last missed dose (Chesney et…”
BackgroundMethodSauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1759-9 · Cited by 18
“, rate your ability to take all your medications as prescribed from 0-very poor to 6–excellent) in the past 30 days [18].”
BackgroundMoving toward a novel and comprehensive behavioral composite of engagement in HIV care
Saberi, P., & Johnson, M. O. (2014) · AIDS Care · doi:10.1080/09540121.2014.986052 · Cited by 14
“Participants’ ARV adherence over the past 30 days was assessed using a 30-day visual analog scale (VAS; Oyugi et al., 2004) and a validated adherence rating scale (Lu et al., 2008) which categorizes adherence as “excellent,” “very good,” “good,” “fair,” “poor,” and “very poor.””
BackgroundMethodAunon, F. M., Wanje, G., Richardson, B. A., Masese, L. N., Odeny, T., Kinuthia, J., Mandaliya, K. N., Jaoko, W. G., Simoni, J. M., & McClelland, R. S. (2023) · BMC Public Health · doi:10.1186/s12889-023-15638-3 · Cited by 14
“Perfect adherence by VAS was higher in intervention participants compared to control participants during every month of the intervention.”
MethodCherrington, A., Krause-Steinrauf, H. J., Bebu, I., Naik, A. D., Walker, E. A., Golden, S. H., & Gonzalez, J. S. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106366 · Cited by 14
Blashill, A. J., Wilson, J. M., Baker, J. S., Mayer, K. H., & Safren, S. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0620-z · Cited by 14
“’’ Recent studies have demonstrated the validity of this item [39], and the validity of its use within routine clinical care for patients with HIV has also been reported [40].”
BackgroundSelf-citationChua, S. S., Siew, P., Lai, M., Tan, C. H., Chan, S. P., Chung, W. W., & Morisky, D. E. (2013) · Cited by 17
Adams, C., Chatterjee, A., Harder, B. M., & Mathias, L. H. (2018) · SSM - Population Health · doi:10.1016/j.ssmph.2018.04.003 · Cited by 14
“In addition, some studies have shown that minority groups in comparison to whites are more likely to hold negative beliefs regarding prescription drugs (Iosifescu, Halm, McGinn, Siu, & Federman, 2008; Lu et al., 2008) and are also more likely to be concerned about the side effects and overreliance on medications (Cope…”
BackgroundResultInfluentialNovel methods to estimate antiretroviral adherence: protocol for a longitudinal study
Saberi, P., Ming, K., Legnitto, D., Neilands, T. B., Gandhi, M., & Johnson, M. O. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s166380 · Cited by 13
“Thinking back over the past 30 days, please rate your ability to take all your medications as prescribed: 1) Excellent, 2) Very good, 3) Good, 4) Fair, 5) Poor, and 6) Very poor.(18) 2.”
Margolis, S. A., Gonzalez, J. S., Spindell, J., Mohamadpour, M., Grant, A. C., & Nakhutina, L. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.09.022 · Cited by 14
McIntosh, R. C., Ironson, G. H., Antoni, M. H., FLETCHER, M. A., & Schneiderman, N. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1126-7 · Cited by 17
“Because our cross-sectional measure of 3-day adherence may not be the optimal index of adherence behavior in HIV patients [108–110], our factor also included an index of reasons why people missed medication doses, the most frequent being ‘‘simply forgot’’.”
BackgroundShahid, N. N., & Dale, S. K. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04157-2 · Cited by 16
“To capture HIV medication adherence, we utilized an item developed in a previous study examining medication adherence among PLWH [59]: ‘Thinking about the past X weeks, how would you rate your ability to take all of your medications as your doctor prescribed them?’”
Gionfriddo, M. R., Hu, Y., Maddineni, B., Kern, M., Hayduk, V. A., Kaledas, W. R., Elder, N., Border, J., Frusciante, K., Kobylinski, M., et al. (2022) · JMIR Formative Research · doi:10.2196/33488 · Cited by 14
“This type of scale is similar to other validated scales for adherence [13,14].”
Callon, W. A., Saha, S., Korthuis, P. T., Wilson, I. B., Moore, R. D., Cohn, J. A., & Beach, M. C. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1231-7 · Cited by 12
Self-citationSekoni, A. O., Obidike, O. R., & Balogun, M. R. (2012) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v4i1.417 · Cited by 13
de Bruin, M., Dima, A. L., Texier, N., & Ganse, E. H. V. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.04.039 · Cited by 15
“In line with research suggesting that self136 reports of behaviour are more accurate amongst people performing a behaviour routinely (most or all of 137 the time) (29), we asked HCPs whether during the last 12 months they performed that activity with the 138 majority of their patients on daily preventer therapy.”
BackgroundPyatak, E. A., Ali, A., Khurana, A. R., Lee, P.-J., Sideris, J. H., Fox, S., Díaz, J., Granados, G., Blanchard, J., McGuire, R., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107386 · Cited by 11
Kelly, J. D., Hubenthal, E. A., Lurton, G., Empson, S. F., Barrie, M. B., Kargbo, B., Wagner, G. J., & Giordano, T. P. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413487327 · Cited by 11
“Second, the different recall periods could have confounded results.(12) Although pill count has a high correlation to electronic monitoring of adherence, the measurement of viral load would have strengthened the outcomes.”
BackgroundReid, R., & Dale, S. K. (2021) · AIDS Care · doi:10.1080/09540121.2021.2001415 · Cited by 14
“measure of participants’ adherence in the past week, past two weeks, and past four weeks (Lu et al., 2008).”
Backgrounde-Health Literacy Scale, Patient Attitudes, Medication Adherence, and Internal Locus of Control
Purcell, D. J., Cavanaugh, G., Thomas-Purcell, K. B., Caballero, J., Waldrop‐Valverde, D., Ayala, V., Davenport, R., & Ownby, R. L. (2023) · HLRP Health Literacy Research and Practice · doi:10.3928/24748307-20230417-01 · Cited by 15
Cook, P. F. (2008) · Research in Nursing & Health · doi:10.1002/nur.20256 · Cited by 12
Crane, H. M., Nance, R. M., Delaney, J. A., Fredericksen, R. J., Church, A. E., Simoni, J. M., Harrington, R. D., Dhanireddy, S., Safren, S. A., McCaul, M. E., et al. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1566-8 · Cited by 11
“Patients receiving ARVs receive several medication adherence items including a self-rating scale item that uses a 30-day time frame [18, 24], a 30-day visual analogue scale (VAS) [22, 36], and several Adult AIDS Clinical Trial Group (AACTG) adherence items [22, 37].”
InfluentialSelf-citationFazeli, P. L., & Turan, B. (2019) · Stigma and Health · doi:10.1037/sah0000170 · Cited by 11
“HIV Outcomes ART Adherence—ART adherence was assessed with a single question, developed by Lu et al (2008): “In the past 4 weeks, how was your ability to take all of your anti-HIV medications that were prescribed by your doctor?””
MethodDale, S. K., Pan, Y., Gardner, N., Saunders, S., Wright, I., Nelson, C. M., Liu, J., Phillips, A., Ironson, G. H., Rodriguez, A. E., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03321-w · Cited by 12
“An item developed in previous studies of adherence [23, 24] was used to capture HIV medication adherence.”
MethodSelf-citationBaisley, K. J., Baeten, J. M., Hughes, J. P., Donnell, D. J., Wang, J., Hayes, R., Watson‐Jones, D., & Celum, C. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0542-9 · Cited by 15
Zúñiga, M. L., Munoz, F. A., Kozo, J., Blanco, E., & Scolari, R. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-0015-y · Cited by 14
“Study authors selected these measures in order to simplify adherence questions for participants, an approach that is supported by the literature, where more global measures of adherence have been shown to accurately assess adherence [27, 28].”
Vacher, H. L., & Chavez, T. A. (2009) · Numeracy · doi:10.5038/1936-4660.2.1.5 · Cited by 12
“(2005), “A definition and operational framework for health numeracy,” contains the definition that is quoted in many papers (e.g., Donelle et al. 2007; Ancker and Kaufman 2007; Lu et al. 2008; Nelson et al. 2008):”
BackgroundDevelopment of an Item Bank to Measure Medication Adherence: Systematic Review
Kwan, Y. H., Oo, L. J. Y., Loh, D. H. F., Phang, J. K., Weng, S. D., Blalock, D. V., Chew, E., Yap, K. Z., Tan, C. Y. K., Yoon, S., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/19089 · Cited by 13
“PROMs from the remaining 160 studies (Multimedia Appendix 2 [33-189]) were excluded due to a lack of consent.”
BackgroundMartínez, O., Fernandez, M. I., Yang, P., Wu, E., Valentin, O., & Johnson, M. O. (2023) · American Journal of Men s Health · doi:10.1177/15579883231167106 · Cited by 11
“defined as reporting condomless anal sex in the absence of reporting adherence to PrEP (for HIV-negative MSM) or full adherence to ART (for HIV-positive MSM) as measured using a validated adherence rating scale (Lu et al., 2008) and the 3-item adherence assessment developed and validated by Wilson et al.”
MethodMusinguzi, N., Muwonge, T. R., Ngure, K., Katabira, E. T., Mugo, N., Burns, B., Baeten, J. M., Heffron, R. A., & Haberer, J. E. (2018) · AIDS · doi:10.1097/qad.0000000000001955 · Cited by 10
“As has been previously done [4,9], self-reported rating and self-reported frequency response categories were assigned quantitative adherence values in 20% increments.”
Lee, J. S., Zopluoglu, C., Andersen, L. S., Stanton, A. M., Magidson, J. F., Kagee, A., Joska, J. A., O’Cleirigh, C. M., & Safren, S. A. (2021) · Public Health Nutrition · doi:10.1017/s1368980021001312 · Cited by 12
“The 30-d recall period aligns with the optimal recall period for HIV medication adherence(23) as well as the operational definition of recent viral load utilised in the present study(24), which therefore makes the HFIAS an ideal measure of food insecurity to utilise among PWH.”
MethodSelf-citationYang, P., & Crane, H. M. (2016) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000276 · Cited by 11
“, sex, race, age), assessments included recent alcohol use (Alcohol Use Disorders Identification Test consumption items (AUDIT-C)) [10], illicit drug use (Alcohol and Substance Involvement Screening Test (ASSIST)) [11], depressive symptoms (Patient Health Questionnaire (PHQ-9)) [12], panic symptoms (PHQ panic symptom…”
MethodEgan, J. E., Ho, K. S., Stall, R. D., Drucker, M. T., Tappin, R., Hendrix, C. W., Marzinke, M. A., Safren, S. A., Mimiaga, M. J., Psaros, C., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002382 · Cited by 10
Self-citationAryal, A., Leibowitz, A. A., Comulada, W. S., Rotheram‐Borus, M. J., Bolan, R., Ocasio, M. A., Swendeman, D. T., & the ATN CARES Study Team (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003272 · Cited by 9
“16,17 Only a small share of the youth in this study was able to continue using PrEP between each 4-month visit, despite reporting high levels of daily adherence when they were taking it.”
BackgroundTreatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
Souliotis, K. N., Peppou, L. Ε., Economou, M. P., Marioli, A., Nikolaidi, S., Saridi, M., Varvaras, D., Paschali, A., & Syrigos, K. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.6.1891 · Cited by 12
“The question was based on work investigating medication adherence in HIV patients (Lu et al., 2008) and in light of evidence substantiating the use of self-report measures in treatment adherence (Hays et al.”
MethodCorrelates of psychological intimate partner violence with HIV care outcomes on patients in HIV care
Fredericksen, R. J., Nance, R. M., Whitney, B. M., Harding, B. N., Fitzsimmons, E., del Río, C., Eron, J. J., Feaster, D. J., Kalokhe, A. S., Mathews, W. C., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-11854-x · Cited by 10
“Adherence to ART was measured as a percentage of HIV medication taken over the past 30 days [45].”
MethodDavis, T. C., Arnold, C. L., Mills, G. M., Lesser, G. J., Brown, W. M., Schulz, R., Weaver, K. E., & Pawloski, P. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111045 · Cited by 12
“The Self-Rating Scale Item is a single question that uses a five-point scale to measure adherence to medication over the last 4 weeks [37,38].”
MethodOkoboi, S., Musaazi, J., King, R. L., Lippman, S. A., Kambugu, A., Mujugira, A., Izudi, J., Parkes-Ratanshi, R. M., Kiragga, A. N., & Castelnuovo, B. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000569 · Cited by 9
“, 2008 [26] who found that 1-month self-report ART adherence was more accurate in measuring ART adherence and predicating virological failure than 3-day or 7-day self-reported ART adherence [26, 27].”
BackgroundCuca, Y. P., Davey, C. H., Corless, I. B., Phillips, J. C., Sierra-Perez, Á. J., Solís-Báez, S. S., Iwu, E., Sabone, M. B., Mulaudzi, M. T., Murphey, C. L., et al. (2023) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000444 · Cited by 10
“Those who are currently taking ARVs are then asked two questions: “ For the past [3 days/30 days] what percent of the time were you able to take your HIV medications exactly as prescribed, ” and entered a percentage on a scale from 0% to 100% (Lu et al., 2008; Walsh et al., 2002).”
Bandiera, C., Ng, R., Mistry, S. K., Harris, E., Harris, M., & Aslani, P. (2025) · International Journal for Equity in Health · doi:10.1186/s12939-025-02415-4 · Cited by 17
Kemp, C. G., Gerth‐Guyette, E., Dube, L., Andrasik, M. P., & Rao, D. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1386-x · Cited by 9
“Adherence: The questionnaire includes the Self-Rating Scale Item, which is a single-item self-report adherence measure that uses adjectives on a 5-point Likert scale [37].”
Methodfor the HIV Prevention Trials Network 063 Team, Ransome, Y., Mayer, K. H., Tsuyuki, K., Mimiaga, M. J., Rodríguez-Díaz, C. E., Srithanaviboonchai, K., Friedman, R. K., Limbada, M., & Safren, S. A. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2206-2 · Cited by 10
Self-citationFactors Associated With Antiretroviral Adherence Among Youth Living With HIV
Arnold, E. M., Kamal, S., Rotheram‐Borus, M. J., Bridges, K., Gertsch, W., Norwood, P., Swendeman, D. T., & the Adolescent Medicine Trials Network (ATN) CARES Team (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003345 · Cited by 11
“Self-reported medication adherence was a single-item measure based on studies by Wilson et al 35 and Lu et al 36 that has been used in clinical trials conducted by the Adult AIDS Clinical Trials Group.”
MethodRosenthal, M. A., Wanje, G., Richardson, B. A., Shafi, J., Wang, L., Masese, L. N., Poole, D. N., Jaoko, W. G., Simoni, J. M., & McClelland, R. S. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03258-0 · Cited by 9
“Adherence in the past 30 days was also evaluated using a validated single-item self-rating scale [28].”
MethodLifson, A. R., Workneh, S., Shenie, T., Ayana, D. A., Melaku, Z., Bezabih, L., Waktola, H. T., Dagne, B., Hilk, R., Winters, K. C., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0274 · Cited by 8
Atal, S., Ray, A., Ahmed, S. N., Singh, P., Fatima, Z., Sadasivam, B., Pakhare, A. P., Joshi, A., & Joshi, R. P. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14316 · Cited by 10
Gerwen, O. T. V., Yiğit, İ., Crockett, K. B., & Turan, B. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03883-3 · Cited by 9
Ramirez-Garcìa, P., & Côté, J. (2011) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2011.04.003 · Cited by 8
“Results in Lu et al. (2008) suggested that self-reported treatment-taking measures during a 1-month period agreed more with the Medication Events Monitoring System (MESM) than when examined in a 1-week or 3-day period.”
ResultGakumo, C. A., Vance, D. E., Moneyham, L. L., Deupree, J. P., & Estrada, C. A. (2013) · Nursing Research and Reviews · doi:10.2147/nrr.s37548 · Cited by 10
“5 The concept of health numeracy has recently been addressed in the literature on HIV-related health outcomes, 6,7 as well as other areas of health, such as anticoagulation control, 8 diabetes, 9 and self-management of asthma.”
Vacher, H. L., & Chavez, T. A. (2008) · Numeracy · doi:10.5038/1936-4660.1.2.2 · Cited by 8
Internal Working Models of Attachment Relationships and HIV Outcomes Among Women Living With HIV
Turan, B., Crockett, K. B., Kempf, M.-C., Konkle‐Parker, D. J., Wilson, T. E., Tien, P. C., Wingood, G. M., Neilands, T. B., Johnson, M. O., Weiser, S. D., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001872 · Cited by 8
Studies of Medication Adherence
Acri, T., & Gross, R. (2013) · Wiley eBooks · doi:10.1002/9781118344828.ch20 · Cited by 8
Medication self-management capacity among older adults living in low-income housing communities
Badawoud, A. M., Salgado, T. M., Lü, J., Peron, E. P., Parsons, P. L., & Slattum, P. W. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.10.026 · Cited by 12
Fredericksen, R. J., Yang, F. M., Gibbons, L. E., Edwards, T. C., Brown, S. L., Fitzsimmons, E., Alperovitz-Bichell, K., Godfrey, M., Wang, A., Church, A. E., et al. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.10.001 · Cited by 9
Lai, P. S. M., Sellappans, R., & Chua, S. S. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00335-y · Cited by 7
Ambrose, P. R., Cuca, Y. P., Baguso, G. N., Hoffmann, T. J., & Dawson-Rose, C. S. (2021) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000292 · Cited by 8
“Participants selfreported adherence to HIV medications based on a single-item adherence rating item, “Thinking back over the past 30 days, rate your ability to take all your medications as prescribed” (very poor, poor, fair, good, very good, excellent; Lu et al., 2008).”
MethodSevelius, J. M., Neilands, T. B., Reback, C. J., Castro, D. A., Dilworth, S. E., Kaplan, R. L., & Johnson, M. O. (2021) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.665723 · Cited by 7
“Research Ethics Approval This study was reviewed and approved by the University of California, San Francisco Institutional Review Board (15-17910) and the Western Institutional Review Board (20181370).”
BackgroundMethodInfluentialMental health and implications for antiretroviral adherence in a multiethnic Asian cohort
Dhaliwal, J. S., Chan, L. G., Goh, J. C. B., Koh, K. H. E., & Wong, C. S. (2021) · Sexually Transmitted Infections · doi:10.1136/sextrans-2021-055153 · Cited by 10
Mathews, W. C., Barker, E., Winter, E., Ballard, C., Colwell, B., & May, S. J. (2008) · AIDS Research and Therapy · doi:10.1186/1742-6405-5-20 · Cited by 7
“Others have noted the same phenomenon for other self report measures [5-8].”
BackgroundAdherence to Medical Advice: Processes and Measurement
Dunbar‐Jacob, J. M., Houze, M. P., Kramer, C., Luyster, F. S., & McCall, M. K. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_7 · Cited by 11
Studies of Medication Adherence
Lauffenburger, J. C., Acri, T., & Gross, R. (2019) · Wiley eBooks · doi:10.1002/9781119413431.ch38 · Cited by 8
The Relationships Among Social Capital, HIV Self-Management, and Substance Use in Women
Webel, A. R., Smith, C. R., Perazzo, J. D., Phillips, J. C., Battashi, H. A., & Dawson-Rose, C. S. (2019) · Western Journal of Nursing Research · doi:10.1177/0193945919842874 · Cited by 7
“HIV antiretroviral medication adherence was assessed with a 30-day adherence visual analog scale (Lu et al., 2008; Walsh, Mandalia, & Gazzard, 2002).”
Farris, K. B., Cadwallader, T., Farley, J. F., Gatwood, K. S., Mackler, E. R., & Gatwood, J. D. (2022) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2022.100163 · Cited by 10
Reid, R., & Dale, S. K. (2023) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00403-z · Cited by 7
“Self-report adherence was assessed by a brief measure that inquired about participants’ adherence in the past week and past two weeks (Lu et al., 2008).”
Gillespie, D., Farewell, D. M., Brookes‐Howell, L., Butler, C., Coenen, S., Francis, N. A., Little, P. S., Stuart, B. L., Verheij, T. J., & Hood, K. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s119256 · Cited by 6
“Although this type of measure is prone to bias, 27,28 by having a daily entry, these biases are likely to be minimized.”
Zhang, T.-T., Ye, J., Xia, S.-L., Zhang, Y.-F., Su, Q., Zhang, Z., & Li, X. (2012) · Infection · doi:10.1007/s15010-012-0320-z · Cited by 6
“assessed every visit and data from the last 30 days were used as an approximation of the patient’s medication behaviour during the 3-month period covered by each questionnaire [18, 19].”
MethodThe use of randomisation-based efficacy estimators in non-inferiority trials
Gillespie, D., Farewell, D. M., Barrett-Lee, P. J., Casbard, A. C., Hawthorne, A. B., Hurt, C. N., Murray, N., Probert, C. S., Stenson, R., & Hood, K. (2017) · Trials · doi:10.1186/s13063-017-1837-3 · Cited by 6
“These methods have been demonstrated to over-estimate adherence in certain circumstances, [19 – 21] but they are methods that are cheap and easy to apply in large-scale randomised controlled trials, so are likely to reflect the type of data obtained in other settings (as opposed to more direct…”
MethodMontgomery, M. C., Ellison, J. E., Chan, P. A., Harrison, L., & van den Berg, J. J. (2021) · Sexual Health · doi:10.1071/sh20207 · Cited by 5
Motivational interviewing and HIV drug adherence.
Jackson, H. C. (2013) · PubMed · Cited by 5
Tabrisky, A. P., Coffin, L. S., Olem, D., Neilands, T. B., & Johnson, M. O. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-037468 · Cited by 5
Cherrington, A., Bebu, I., Krause-Steinrauf, H. J., Hoogendoorn, C. J., Crespo-Ramos, G., Presley, C. A., Naik, A. D., Balasubramanyam, A., Gramzinski, M. R., Killean, T., et al. (2024) · Diabetes Care · doi:10.2337/dc23-0642 · Cited by 7
Shorey, R. C., Strauss, C. V., Woods, W. C., & Cornelius, T. L. (2016) · Partner Abuse · doi:10.1891/1946-6560.7.2.125 · Cited by 5
“For example, another potential problem with current IPV measures is the wording of the items themselves (Hamby, 2014; Hamby & Koss, 2003) and the instructions given to participants (Fisher, 2009; Lu et al., 2008; Vautier, Mullet, & Bourdet-Loubère, 2003).”
BackgroundStekler, J. D., Scanlan, J. M., Simoni, J. M., Crane, H. M., Fredericksen, R. J., Marquard, J. L., & Saver, B. G. (2018) · AIDS Education and Prevention · doi:10.1521/aeap.2018.30.5.357 · Cited by 5
Impact of Response Scale Features on Survey Responses to Behavioral Questions
Keusch, F., & Yan, T. (2019) · doi:10.1002/9781119083771.ch7 · Cited by 5
Medication adherence feedback with older adults with cognitive impairment: A mixed methods study
Sullivan, K. L., Hallowell, E. S., Goldstein, A., Commissariat, P. V., Daiello, L. A., Davis, J. D., & Margolis, S. A. (2025) · The Clinical Neuropsychologist · doi:10.1080/13854046.2024.2447094 · Cited by 4
“This user-friendly prompt has been previously validated against MEMS adherence and biological markers of disease control in multiple chronic illness populations (Gonzalez et al., 2013; Lu et al., 2008).”
Taylor, A., Hayes, R., Nwokolo, N. C., Whitlock, G. G., Dosekun, O., McCormack, S., Gafos, M., & Evangeli, M. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04151-8 · Cited by 4
Yeneakal, K. A., Teferi, G. H., Mihret, T. T., Mengistu, A. K., Tizie, S. B., & Tadele, M. M. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03106-4 · Cited by 12
“People may forget details, or give answers that are not entirely accurate, which makes it harder to assess how well they are actually following their treatment [11, 12].”
InfluentialShapira, A., Kane, N. S., Tanenbaum, M. L., Hoogendoorn, C. J., & Gonzalez, J. S. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108205 · Cited by 4
Maierhöfer, S., Waltering, I., Jacobs, M., Würthwein, G., Appelrath, M., Koling, S., & Hempel, G. (2022) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-022-00495-z · Cited by 6
“Adherence is assessed at t 0 and t 3 with an adaptation of the validated Self-Rating Scale Item (SRSI) [31, 32].”
MethodCrane, H. M., Fredericksen, R. J., Church, A. E., Harrington, A., Ciechanowski, P. S., Magnani, J., Nasby, K., Brown, T., Dhanireddy, S., Harrington, R. D., et al. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5492 · Cited by 6
“…Patient’s Health Questionnaire (PHQ-9) measure of depression symptoms [69,70], medication adherence (several items with varying recall periods) [71,72], and substance use (Alcohol Use Disorders Identification Test Consumption Items and Alcohol, Smoking, and Substance Involvement Screening Test)…”
Self-citationMcInnes, D. K., Hardy, H., Goetz, M. B., Skolnik, P. R., Brewster, A. L., Hofmann, R., & Gifford, A. L. (2012) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/1545109712454333 · Cited by 4
Self-citationThe use of randomisation-based efficacy estimators in non-inferiority trials
Gillespie, D., Hood, K., Farewell, D. M., Hawthorne, A. B., Probert, C. S., Stenson, R., Barrett-Lee, P. J., Casbard, A. C., & Murray, N. (2015) · Trials · doi:10.1186/1745-6215-16-s2-p129 · Cited by 4
Adherence to HIV care among HIV-positive pregnant women in Nigeria
Oginni, M. O., Aremu, O. O., Olowokere, A. E., Ayamolowo, S. J., & Komolafe, A. O. (2018) · African Journal of Midwifery and Women s Health · doi:10.12968/ajmw.2018.12.1.28 · Cited by 4
Psaros, C., Stanton, A. M., Bedoya, C. A., Mosery, N., Evans, S. M., Matthews, L. T., Haberer, J. E., Vangel, M. G., Safren, S. A., & Smit, J. A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035465 · Cited by 5
Self-citationGarey, L., Wirtz, M. R., Labbe, A. K., Zvolensky, M. J., Smits, J. A. J., Giordano, T. P., Rosenfield, D., Robbins, G. K., Levy, D. E., McKetchnie, S. M., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106420 · Cited by 3
Biello, K. B., Chan, P. A., Ndoye, C. D., Nelson, L. R., Nelson, E., SILVA, V. Y. N. E. D., Kwak, E., Napoleon, S. C., Orellana, C. C., Richards, O. G., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-17710-y · Cited by 4
“In line with our prior trials and available evidence regarding the validity and reliability of self-reported adherence assessments, participants are asked to rate their adherence frequency (e.g., “all the time”) and report missed doses [23].”
ResultBizier, A., Jones, A., Businelle, M. S., Kezbers, K. M., Hoeppner, B. B., Giordano, T. P., Thai, J. M., Charles, J. J., Montgomery, A., Gallagher, M. W., et al. (2024) · JMIR Research Protocols · doi:10.2196/52090 · Cited by 4
“ART adherence is assessed using 2 measures: the ART Adherence Scale [79], which consists of 7 items that assess adherence to ART medication regimens and attendance of HIV-specific medical appointments, and the AIDS Clinical Trial Group Adherence Baseline Questionnaire [80], which assesses ART…”
MethodScott, T. M., Byrd, D., Rentería, M. A., Coulehan, K., Miranda, C., Fuentes, A., & Mindt, M. R. (2017) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2017.08.002 · Cited by 3
“The first study strength was the use of well-validated measures of substance use, nonsomatic depressive symptomatology, and neurocognitive function, as well as a structured, robust, and clinically useful measure of self-reported adherence (30-day VAS; Lu et al., 2008).”
He, Q., Hao, C., Pan, D., Liu, C., Zhou, K., Li, J., Zhong, H., Du, P., Li, Q., Lau, J. T. F., et al. (2022) · International Journal of Behavioral Medicine · doi:10.1007/s12529-022-10120-7 · Cited by 3
“Though there is no consensus on the definition of self-reported ART adherence [48] and both 80% and 100% adherence had been applied as cutoff values for optimal adherence [49], people should be careful when comparing our findings with those of other studies especially when the definitions of ART adherence are differen…”
ResultDreyer, A. J., Nightingale, S., Andersen, L. S., Lee, J. S., Gouse, H., Safren, S. A., O’Cleirigh, C., Thomas, K. G. F., & Joska, J. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-03992-7 · Cited by 3
“Methods of rating adherence using time-frames of longer than 1 week have been shown to be more accurate than 1 week or 3 day time-frames [74].”
Self-citationPsaros, C., Goodman, G. R., McDonald, V., Ott, C., Blyler, A. P., Rivas, A. M., Shan, L., Campbell, M., Underwood, E., Krakower, D., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075250 · Cited by 3
Safren, S. A., Lee, J. S., Andersen, L. S., Stanton, A. M., Kagee, A., Kirakosian, N., O’Cleirigh, C. M., & Joska, J. A. (2024) · AIDS Care · doi:10.1080/09540121.2024.2308750 · Cited by 3
“Adherence was assessed with two self-reported items asking about the past two weeks (Lu et al., 2008).”
Self-citationBaghal, T. A. (2014) · Journal of Methods and Measurement in the Social Sciences · doi:10.2458/v5i2.18476 · Cited by 8
Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices
Mackler, E. R., Scappaticci, G. B., Salgado, T. M., Petersen, L., Davis, E. J., Peltier, E., Griggs, J. J., Sabo, R., & Farris, K. B. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00058 · Cited by 3
Sauceda, J. A., Lisha, N. E., Neilands, T. B., Christopoulos, K., Mathews, W. C., Levison, J. H., Dennis, A. M., & Johnson, M. O. (2018) · Journal of Behavioral Medicine · doi:10.1007/s10865-018-9986-8 · Cited by 3
White, I., Judd, A., Castro, H., Chappell, E., & on behalf of the Adolescents and Adults Living with Perinatal HIV (AALPHI) Steering Committee (2024) · AIDS Care · doi:10.1080/09540121.2023.2300984 · Cited by 2
“The Last Month Adherence measure was selected as the dependent variable for all models as studies suggest that self-reported adherence measures with longer recall periods are more accurate (Farley et al., 2008; Lu et al., 2008).”
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial
Cooper, S. E., Zhang, S., Haines, D., Mayer, K. H., Amico, K. R., Landovitz, R. J., Hendrix, C. W., Marzinke, M. A., Chege, W., McCauley, M., et al. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04451-7 · Cited by 3
“However, it should be noted that estimation of adherence by 30-day recall has been validated and demonstrated as having lower rates of over-reporting of HIV medication adherence compared to 3-day and 7-day recall [ 40].”
BackgroundRodríguez-Díaz, C. E., Zangeneh, S. Z., Chen, Y., Guo, X., Tsuyuki, K., Ransome, Y., Friedman, R. K., Srithanaviboonchai, K., Roberts, S. T., Mimiaga, M. J., et al. (2025) · AIDS Education and Prevention · doi:10.1521/aeap.2025.37.2.89 · Cited by 2
Self-citationLodge, W., Rawat, S. M., Dange, A., Chaudary, J., Agénor, M., Anand, V. R., Operario, D., Mimiaga, M. J., & Biello, K. B. (2025) · International Journal of Transgender Health · doi:10.1080/26895269.2025.2527828 · Cited by 3
Metadata
- Authors
- Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., & Wilson, I. B.
- Affiliations
- Tufts Medical Center (US)
- Harvard University (US)
- Boston University (US)
- Corresponding author
- Wilson, Ira B.
- Venue
- AIDS and Behavior
- Published
- 2007-06-19
- Volume
- 12
- Issue
- 1
- Pages
- 86-94
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2054763716
- Cited by
- 361
- References
- 44
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 21 · 2022: 17 · 2021: 30 · 2020: 21 · 2019: 18 · 2018: 27 · 2017: 19 · 2016: 29 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 18
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- AIDS and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Center for AIDS Research, University of Washington
- Research England
- National Institute on Drug Abuse (R01DA015679)
- National Institute of Allergy and Infectious Diseases (P30-AI 42853, P30AI042853)
- National Center for Research Resources (M01 RR-00054, M01RR000054, K24RR020300)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Keywords
- HIV treatment adherence, antiretroviral therapy, self-report measures, recall period, overreporting, medication event monitoring system, measurement accuracy, rating scales
- MeSH terms
- Adult, Electronics, Female, Humans, Male, Patient Compliance, Surveys and Questionnaires, Mental Recall, Self Administration, Self Disclosure, Time Factors, HIV Infections, Treatment Outcome, Drug Monitoring, Cross-Over Studies, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.